The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

The launch of the GSK ‘Understanding Shingles’ research findings aims to raise awareness and address the lack of knowledge ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University ...

Check the time stamp on this data. Updated AI-Generated Signals for Gsk Plc American Depositary Shares (each Representing Two ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

The RespiriNTM project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU) under grant agreement No 853932. This Joined Undertaking receives support from the European ...

A city off-licence has had its licence suspended for six weeks after the owner was caught twice selling illegal goods.

GSK & Cambridge University announce new five-year collaboration in kidney and respiratory disease: London, UK Tuesday, October 22, 2024, 10:00 Hrs [IST] GSK plc announced it is in ...